Risk modelling study suggests aspirin’s harms outweigh benefits for younger women For most women, the long-term benefits of aspirin do not outweigh the increase in major gastrointestinal bleeding, say researchers.…
Chemoprevention with tamoxifen cuts risk of breast cancer by almost 30% Tamoxifen used in primary prevention cuts the risk of breast cancer by around 30% and this benefit lasts for at least 20 years, a long-term follow-up of the International Breast Cancer Intervention Study shows.…